六君子汤联合莫沙必利治疗糖尿病胃轻瘫的效果研究.docVIP

六君子汤联合莫沙必利治疗糖尿病胃轻瘫的效果研究 　　[摘要] 目的 对六君子汤联合莫沙必利应用于糖尿病胃轻瘫临床治疗中的效果进行分析研究。 方法 选取于2013年8月―2015年1月期间在该院接受治疗的糖尿病胃轻瘫患者89例，并随机分为对照组（43例）和实验组（46例），观察莫沙必利与六君子汤联合莫沙必利的效果并进行比较。 结果 实验组患者的治愈率为58.7%，治疗总有效率为91.3%，显著高于对照组患者的23.3%和72.1%；实验组患者的不良反应发生率为8.7%，复发率为6.5%，均显著低于对照组患者的27.9%和25.6%；同时实验组患者的胃固体的排空时间显著短于对照组，差异有统计学意义（P0.05）。结论 六君子汤联合莫沙必利应用于糖尿病胃轻瘫临床治疗中的效果十分显著，安全有效，值得大力推广。[关键词] 六君子汤；莫沙必利；糖尿病胃轻瘫[中图分类号] R259 　　[文献标识码] A 　　[文章编号] 1672-4062（2016）03（a）-0039-03Study on the Effect of Six Gentlemen Decoction Combined with Mosapride in the Treatment of Diabetic GastroparesisHUANG RongPharmacy Department，the Geriatric Rehabilitation Hospital of Nantong City， Nantong， Jiangsu Province，226001 China[Abstract] Objective To Liujunzi Decoction Combined with Mosapride have application in diabetic Gastro paresis clinical treatment effect were analyzed. Methods Selection in August 2013 - January 2015 treated in our hospital during the period of 89 patients with diabetic gastroparesis， and randomly divided into moser will benefit group （43 cases） and the combined group （46 cases）， observe the moser will benefit associated with 6 gentleman soup moser will benefit and the effect of the comparison. Results Patients in the combination group cure rate of 58.7%， the total efficiency of the treatment was 91.3%， significantly higher than that of citrate mosapride group were 23.3% and 72.1%. The adverse reactions of patients in the combination group occurrence rate was 8.7%， the recurrence rate was 6.5%， significantly lower than that of Mosapride will benefit groups were 27.9% and 25.6%； while joint group patients with gastric solid emptying time was significantly shorter in MOSSA tiapride group， difference between the two groups by t test， statistical significance （P 0.05），具有可比性。1.2 方法两组患者入院后均给予常规糖尿病治疗，主要包括对患者进行饮食控制，给予患者优质低蛋白、低脂、低糖、高纤维素的饮食，并让患者养成少食多餐的饮食习惯，给予患者相应的降糖药物，使患者的血糖水平得以有效控制[2]。1.2.1 对照组 该组的43例患者在上述常规治疗措施的基础上接受单纯莫沙必利进行治疗：5 mg/次的莫沙必利（国药准字，3次/d于饭前30 min口服[3]。1.2.2 实验组 该组的46例患者在上述常规治疗措施的基础上接受